Company Filing History:
3 out of 3,222 
1 out of 98 
1 out of 1 Years Active: 2013-2016
Title: **Camelia Adams: Pioneering Innovations in Immunotherapy**
Introduction
Camelia Adams, based in San Jose, CA, is a distinguished inventor known for her significant contributions to the field of immunotherapy. With an impressive portfolio of five patents, her innovative work focuses on the development of anti-FcRH5 antibodies aimed at treating hematopoietic tumors in mammals. Adams' breakthroughs in this area are paving the way for advanced treatment options in oncology.
Latest Patents
Among her latest patents is "Anti-FcRH5 antibodies and immunoconjugates and methods of use." This invention encompasses compositions of matter designed for the treatment of hematopoietic tumors in mammals, highlighting the therapeutic potential of these antibodies. Additionally, she holds a patent for a method of determining the presence of FcRH5 in biological samples, which involves exposing such samples to an isolated monoclonal anti-FcRH5 antibody. These developments signify a critical advancement in diagnostic and therapeutic techniques in cancer treatment.
Career Highlights
Camelia has collaborated with leading biotech firms, notably Genentech, Inc., where she has leveraged her expertise to drive research and innovation in antibody therapies. Her dedication to advancing medical science has cemented her status as a respected figure in her field.
Collaborations
Throughout her career, Adams has had the opportunity to work alongside talented professionals, including Kristi Elkins and Andrew G. Polson. These collaborations have not only enriched her research but also fostered a collaborative spirit in the pursuit of groundbreaking medical innovations.
Conclusion
Camelia Adams exemplifies the essence of innovation in the realm of immunotherapy. Through her patents and collaborative endeavors, she is making significant strides in improving treatment options for patients with hematopoietic tumors. Her work is a testament to the transformative power of inventors in shaping the future of medicine.